HMBS p.Arg167Pro
c.500G>C · rs118204095 · VCV1509204
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9956 | likely pathogenic ✓ concordant with ClinVar · top 6% in HMBS |
|---|---|---|
| REVEL | 0.95 | strongly pathogenic-leaning |
| SaProt | LLR -14.76 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · G>A here scores Δ0.80 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 2.2, phastCons 1 |
| Regional constraint | o/e 0.87 | unconstrained · MANE · 8,246 bp · p 0.0046 · regional, not allelic |
| Overall | ||
| CADD | 34.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- HMBS
- Protein
- p.Arg167Pro
- Coding
- c.500G>C
- MANE Select
- NM_000190
- dbSNP
- rs118204095
- Type
- single nucleotide variant
- Location
- chr11:119091414 (GRCh38)
- Gene constraint
- LOEUF 0.546 · pLI 0.81 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 90.54 · 11 PDB
- Residue 167
- a UniProt-annotated variant site (in aip, encep and lencep; decreased hydroxymethylbilane synthase activity due to defective enzyme-intermediate complexes turnover and regeneration of free enzyme molecules); a UniProt-annotated variant site (in aip and encep; severely decreased hydroxymethylbilane synthase activity; results in less than 5% of wild-type activity; 2-fold decrease of vmax; 33-fold increase of km)
Disease context
acute intermittent porphyria — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: encephalopathy, porphyria-relatedleukoencephalopathy, porphyria-related
For Acute intermittent porphyria (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adolescent, Adult
- Prevalence
- <1 / 1 000 000 (Europe)
Similar variants
- HMBS p.Arg167Gln Pathogenic/Likely pathogenic ★★ same residue
- HMBS p.Arg167Trp Pathogenic ★★ same residue
- HMBS p.Arg167Leu Pathogenic same residue
- HMBS p.Arg167Gly Uncertain significance ★ ⚠ same residue
- HMBS c.160+5G>C Pathogenic/Likely pathogenic ★★ same condition
- HMBS c.345-1G>A Pathogenic ★★ same condition
- HMBS c.613-1G>A Pathogenic ★★ same condition
- HMBS c.826-2A>T Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/hmbs-p-arg167pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown